Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
IntroductionHepatocellular carcinoma (HCC) is a high-grade malignant disease with unfavorable prognosis, and although surgical therapy is necessary, not all patients with HCC are suitable candidates for surgery. Downstaging as preoperative therapeutic strategy, which can convert unresectable HCC int...
Guardado en:
Autores principales: | Xinyu Chen, Lin Lai, Jiazhou Ye, Lequn Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09cb52965d4442fba09c01aa45948fc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Hui-Chuan Sun, et al.
Publicado: (2021) -
Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021) -
Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study
por: Weili Qi, et al.
Publicado: (2021) -
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China:
a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021) -
Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
por: He Aoxiao, et al.
Publicado: (2021)